MitoRx Therapeutics

Oxford, United Kingdom · Founded 2021 · Privately Held (backing)

Developer of small molecule therapeutics designed for weight loss with muscle preservation in obesity-related and cardiometabolic conditions. MitoRx Therapeutics is based in Oxford, United Kingdom and was founded in 2021. Its last reported valuation was $31.4 million in Nov 2025. It has raised $17.5 million.

Last reported valuation
$31.4M
Oct 2026
Priced at
—
Total raised
$17.5M
Last round
—

Who backs MitoRx Therapeutics?

13 investors
InvestorType
Future Planet CapitalVenture capital
UK Innovation & Science Seed FundVenture capital
WCS NomineesOther
Empirical VenturesVenture capital
The Betsy and Jesse Fink Family FoundationOther
Exeter Innovation—
Longevitytech.fund—
Oshen Holdings—
Oxford Technology Management—
Panacea Capital—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MitoRx Therapeutics investors

13 investors are on record for MitoRx Therapeutics, including Future Planet Capital, UK Innovation & Science Seed Fund, WCS Nominees and Empirical Ventures.

Free account
More of MitoRx Therapeutics with a free account
  • ·The complete investor list: 13 names
  • ·Watch MitoRx Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like MitoRx Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View